LU90343I2 - Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle) - Google Patents

Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle)

Info

Publication number
LU90343I2
LU90343I2 LU90343C LU90343C LU90343I2 LU 90343 I2 LU90343 I2 LU 90343I2 LU 90343 C LU90343 C LU 90343C LU 90343 C LU90343 C LU 90343C LU 90343 I2 LU90343 I2 LU 90343I2
Authority
LU
Luxembourg
Prior art keywords
hemihydrate
eur
estradiol
active
combination
Prior art date
Application number
LU90343C
Other languages
English (en)
Original Assignee
Pre Jay Holdings Ltd
Woco Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90343(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pre Jay Holdings Ltd, Woco Investments Ltd filed Critical Pre Jay Holdings Ltd
Publication of LU90343I2 publication Critical patent/LU90343I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU90343C 1983-08-05 1999-01-27 Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle) LU90343I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (1)

Publication Number Publication Date
LU90343I2 true LU90343I2 (fr) 1999-03-29

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
LU90107C LU90107I2 (fr) 1983-08-05 1997-07-21 Combinaison d'oestrogènes et d'acétate de médroxy progestérone chevalin
LU90343C LU90343I2 (fr) 1983-08-05 1999-01-27 Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle)
LU90697C LU90697I2 (fr) 1983-08-05 2000-12-13 Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt)
LU90696C LU90696I2 (fr) 1983-08-05 2000-12-13 Combinaison d'oestradiol et d'ac-tate de m-droxy progesterone (indivina)
LU91096C LU91096I2 (fr) 1983-08-05 2004-07-30 Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU90107C LU90107I2 (fr) 1983-08-05 1997-07-21 Combinaison d'oestrogènes et d'acétate de médroxy progestérone chevalin

Family Applications After (3)

Application Number Title Priority Date Filing Date
LU90697C LU90697I2 (fr) 1983-08-05 2000-12-13 Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt)
LU90696C LU90696I2 (fr) 1983-08-05 2000-12-13 Combinaison d'oestradiol et d'ac-tate de m-droxy progesterone (indivina)
LU91096C LU91096I2 (fr) 1983-08-05 2004-07-30 Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but.

Country Status (12)

Country Link
US (2) US4826831A (fr)
EP (1) EP0136011B2 (fr)
AT (1) ATE147987T1 (fr)
CA (1) CA1240927A (fr)
DE (5) DE10199001I2 (fr)
DK (2) DK165390C (fr)
IL (1) IL72556A (fr)
LU (5) LU90107I2 (fr)
MX (1) MX9203720A (fr)
NL (5) NL970026I1 (fr)
NZ (1) NZ209066A (fr)
PH (1) PH24052A (fr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CH674618A5 (fr) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ATE66149T1 (de) * 1987-07-06 1991-08-15 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (fr) * 1987-12-22 1989-06-28 Akzo N.V. Unité de dosage pharmaceutique pour traiter les troubles climactériques et l'ostéoporose
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
PH30747A (en) * 1989-03-10 1997-10-17 Endorech Inc Combination therapy for the treatment of estrogen sensitive disease.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (fr) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Compositions pharmaceutiques d'oestrogenes conjugues et leurs modes d'emploi
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1098653A2 (fr) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
CA2311937A1 (fr) * 1998-10-09 2000-04-20 Pharmacia & Upjohn Company Llc Acetate de medroxyprogesterone administre par voie sous-cutanee en vue du traitement de la menopause et de l'endometriose
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) * 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
JP2004524354A (ja) * 2001-03-16 2004-08-12 ワイス エストロゲン補充療法
IL157944A0 (en) * 2001-03-16 2004-03-28 Wyeth Corp Hormone replacement therapy
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
WO2002092102A2 (fr) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Traitement d'etats lies a un deficit en hormones par administration de progestatifs
WO2003006027A1 (fr) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combinaison de drospirenone et d'un sulfamate d'oestrogene destinee a une hormonotherapie substitutive
WO2003018026A1 (fr) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Utilisation de composes oestrogeniques combines avec des composes progestogeniques dans une hormonotherapie substitutive
PT1453521E (pt) 2001-12-05 2013-10-08 Teva Womens Health Inc Contracetivos orais para prevenir a gravidez e diminuir a sintomatologia pré-menstrual
US20030216366A1 (en) * 2002-04-03 2003-11-20 Leonard Thomas W. Step-down estrogen therapy
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
RU2340345C2 (ru) * 2002-08-28 2008-12-10 Роберт КАСПЕР Схема восполнения эстрогена
EP1462106A1 (fr) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Compositions pharmaceutiques et trousses comprenant 17-beta estradiol et progesteron pour le traitement des troubles gynecologiques
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (fr) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Procede d'administration d'oestrogenes et de progestatifs
WO2004098517A2 (fr) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methodes de traitement hormonal faisant appel a des schemas contraceptifs a cycle prolonge
CA2771944A1 (fr) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Procedes de traitement hormonal utilisant des posologies contraceptives avec administration continue d'oestrogenes
AU2004275470B2 (en) * 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
PT1670440E (pt) * 2003-09-29 2014-08-22 Novo Nordisk Femcare Ag Formulações hrt
CA2566811A1 (fr) * 2004-05-26 2005-12-15 Wyeth Compositions et methodes pour traiter un trouble dysphorique premenstruel
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (fr) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
JP2009521533A (ja) * 2005-12-27 2009-06-04 デュラメド ファーマシューティカルズ インコーポレーティッド 結合型エストロゲン組成物、アプリケーター、キット、ならびにそれらの作製および使用の方法
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
EP2164498A4 (fr) 2007-06-04 2010-09-08 Univ California Association d'hormone de grossesse pour le traitement de maladies autoimmunes
CA2795801C (fr) 2010-04-15 2018-05-29 Bayer Intellectual Property Gmbh Formes pharmaceutiques orales solides a tres faible dose pour hrt
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3137088B1 (fr) 2014-04-28 2023-08-30 The Regents of The University of California Conditionnement pharmaceutique pour thérapie à l'estriol pour le traitement de la sclérose en plaques
EP3137087B1 (fr) 2014-04-28 2023-09-06 The Regents of the University of California Combinaison d'oestrogènes pour le traitement de la sclérose en plaques
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2016036719A1 (fr) 2014-09-02 2016-03-10 The Regents Of The University Of California Thérapie oestrogénique pour traitement l'atrophie de la matière grise cérébrale et le handicap associé
ES2957543T3 (es) 2014-09-29 2024-01-22 Univ California Composiciones y métodos para mantener la función cognitiva
WO2016160832A1 (fr) 2015-03-30 2016-10-06 The Regents Of The University Of California Méthodes de surveillance de thérapie à base d'œstriol
EA035687B1 (ru) 2015-06-18 2020-07-27 Эстетра Спрл Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3178291A1 (fr) 2016-08-05 2018-04-12 Estetra Srl Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
LU91096I2 (fr) 2004-11-30
NZ209066A (en) 1988-01-08
DK377084A (da) 1985-02-06
EP0136011A3 (fr) 1986-07-16
DE3486442T3 (de) 2005-05-12
PH24052A (en) 1990-03-05
NL300033I2 (nl) 2004-04-01
IL72556A (en) 1989-05-15
DE3486442T2 (de) 1997-06-05
DE10199010I1 (de) 2002-05-08
US4826831A (en) 1989-05-02
DK165390C (da) 2004-04-26
EP0136011B2 (fr) 2004-06-09
LU90697I2 (fr) 2001-02-13
DE10075037I1 (de) 2001-03-01
DK377084D0 (da) 1984-08-03
CA1240927A (fr) 1988-08-23
NL300022I2 (nl) 2004-04-01
ATE147987T1 (de) 1997-02-15
DE10199010I2 (de) 2010-01-28
DK175317B1 (da) 2004-08-16
NL970026I1 (nl) 1997-10-01
NL300033I1 (nl) 2001-03-01
DK165390B (da) 1992-11-23
LU90696I2 (fr) 2001-02-13
DE19775086I2 (de) 2001-08-23
MX9203720A (es) 1992-07-31
DK200400365A (da) 2004-03-04
NL970037I1 (nl) 1998-02-02
NL980038I1 (nl) 1999-02-01
NL300022I1 (nl) 2001-01-02
DE10199001I2 (de) 2010-07-08
LU90107I2 (fr) 1997-12-17
NL980038I2 (nl) 2005-06-01
DE3486442D1 (de) 1997-03-06
NL970037I2 (nl) 2004-04-01
IL72556A0 (en) 1984-11-30
DE10199001I1 (de) 2002-03-14
USRE36247E (en) 1999-07-06
DE10075037I2 (de) 2010-01-28
EP0136011B1 (fr) 1997-01-22
EP0136011A2 (fr) 1985-04-03

Similar Documents

Publication Publication Date Title
LU90343I2 (fr) Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle)
FI950774A (fi) Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon
ES2123547T3 (es) Formulaciones, metodos y dispositivos contraceptivos transdermicos.
JPS5799511A (en) Denture stabilizing agent
EP0382162A3 (fr) Procédé de préparation de 14-alpha hydroxy-4-androstène-3,6,17 trione
JPS5441671A (en) Semiconductor device
JPS5231565A (en) Sewage disposal
JPS53114886A (en) Skin packaging film
JPS5328164A (en) Maleimide derivatives
JPS5398182A (en) Method of forming fluorescent substance film
JPS6476853A (en) Sanitary article
JPS5294818A (en) Preparation of al alloy sheet having both strength, toughness and duct ility
JPS51112530A (en) Compositions for the toiletry
JPS51139835A (en) Treatment agent for giving release properties
JPS51144100A (en) Stair device for evacuation
JPS5225291A (en) Fixing or tightening fittings for wire, etc.
JPS51143097A (en) Preparation of polyhydantoin
JPS51150428A (en) Newspaper adjusting case
JPS53108304A (en) Check system for overlapped long-linked diffused pulse
JPS535336A (en) Engine stopping device
JPS52122343A (en) Lividomycin derivatives and preparation thereof